Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
TeamViewer AG

Start price
Target price
Perf. (%)
€12.91
22.11.21
€18.00
22.11.22
-4.88%
23.11.22

Could be worthwhile Investment >10% per year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€260.50
21.11.21
€304.00
21.11.22
-37.83%
30.03.22

Could be worthwhile Investment >10% per year
buy
JOYY Inc. ADR

Start price
Target price
Perf. (%)
€50.20
21.11.21
€70.00
21.11.22
-47.81%
22.11.22

Faurecia S.A.

Start price
Target price
Perf. (%)
€45.93
20.11.21
€43.00
20.11.22
-10.95%
26.11.21

Could be worthwhile Investment >10% per year
Royal Mail plc

Start price
Target price
Perf. (%)
€5.93
19.11.21
-
19.11.22
-2.70%
10.12.21

Probably not worthwhile Investment
Elis Services S.A.

Start price
Target price
Perf. (%)
€15.31
18.11.21
€14.50
08.05.22
-2.48%
22.11.21

Could be worthwhile Investment >10% per year
Eurofins Scientific SE

Start price
Target price
Perf. (%)
€106.52
17.11.21
€100.00
17.11.22
6.67%
26.11.21

Could be worthwhile Investment >10% per year
buy
Nemetschek SE

Start price
Target price
Perf. (%)
€112.05
17.11.21
€120.00
17.11.22
-33.42%
20.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
High valuation
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year
buy
Sociedad Quimica y Minera de Chile SA ADR

Start price
Target price
Perf. (%)
€56.00
16.11.21
-
16.11.25
-25.00%
11.03.24

Could be worthwhile Investment >10% per year
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€49.81
16.11.21
€60.00
31.12.23
-16.94%
08.05.23

Could be very worthwhile Investment >20% year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€222.70
16.11.21
€250.00
16.11.22
-18.12%
13.01.22

Significant cyclical dependencies
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€212.70
15.11.21
€170.00
15.11.22
-35.14%
28.04.22

Good rating
Medium risks for its business
Very low/no dividend yield expected
high free float
Amarin Corp. ADR

Start price
Target price
Perf. (%)
€3.40
15.11.21
€2.00
31.12.23
-15.88%
16.12.21

Could be very worthwhile Investment >20% year
Commerzbank AG

Start price
Target price
Perf. (%)
€7.09
15.11.21
-
15.11.22
-7.31%
06.12.21

Risky Investment
Revenue decline > 20% expected
buy
New Oriental Education & Technology Group

Start price
Target price
Perf. (%)
€1.84
15.11.21
-
15.11.22
2.17%
27.11.21

Risky Investment
buy
New Oriental Education & Technology Group ADR

Start price
Target price
Perf. (%)
€19.20
15.11.21
-
15.11.22
1.56%
27.11.21

Risky Investment
buy
TAL Education Group ADR

Start price
Target price
Perf. (%)
€3.64
15.11.21
-
15.11.22
20.88%
27.11.21

Risky Investment
buy
Sociedad Quimica y Minera de Chile SA ADR

Start price
Target price
Perf. (%)
€58.20
15.11.21
€70.00
15.11.22
-3.78%
27.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€210.00
14.11.21
€185.00
14.11.22
-25.98%
15.11.22

EBIT growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Higher risks for its business
buy
Ballard Power Systems Inc.

Start price
Target price
Perf. (%)
€16.30
14.11.21
€10.00
14.11.22
-62.67%
15.11.22

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
ROE lower than 10% per year
buy
Encavis AG

Start price
Target price
Perf. (%)
€17.99
14.11.21
€19.70
14.11.22
-9.01%
28.11.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€199.52
14.11.21
€230.00
14.11.22
-19.81%
18.03.22

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€13.55
13.11.21
-
13.11.22
-69.88%
14.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
buy
Cronos Group Inc.

Start price
Target price
Perf. (%)
€5.39
13.11.21
-
07.11.25
-56.42%
02.06.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model